Nanoparticles of Lactic Acid Polymer with Rifampicin Decrease the P-gp Multidrug Transporter Activity in Human Macrophages
- 1 September 2022
- journal article
- research article
- Published by Allerton Press in Moscow University Biological Sciences Bulletin
- Vol. 77 (3) , 152-158
Abstract
The problem of reduced effectiveness of antituberculosis drugs is currently associated not only with the development of drug resistance in the pathogen butKeywords
This publication has 20 references indexed in Scilit:
- The toxicity of rifampicin polylactic acid nanoparticles againstMycobacterium bovis BCGand human macrophage THP-1 cell lineIOP Conference Series: Materials Science and Engineering, 2015
- M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposideBMC Cancer, 2015
- Migration properties of adipose-tissue-derived mesenchymal stromal cells cocultured with activated monocytes in vitroCell and Tissue Biology, 2014
- Synthesis, Colloidal Properties and Cytotoxicity of Biopolymer NanoparticlesApplied Biochemistry and Biotechnology, 2014
- P-glycoprotein Trafficking as a Therapeutic Target to Optimize CNS Drug Delivery2014
- Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cellsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- The mitochondrial fluorescent dye rhodamine 123 is a high‐affinity substrate for organic cation transporters (OCTs) 1 and 2Fundamental & Clinical Pharmacology, 2012
- Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNAInternational Journal of Pharmaceutics, 2007
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cellsAmerican Journal of Physiology-Cell Physiology, 1997